Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,576.00    22.00 (0.86%)
Bid:
2,568.00
Ask:
2,570.00
Spread: 2.00 (0.078%)
Market Cap: £8.27b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

16 Dec 2015 07:00

RNS Number : 1475J
Bunzl PLC
16 December 2015
 



 

16 December 2015

 

BUNZL PRE CLOSE STATEMENT AND ACQUISITIONS IN FRANCE, CHILE AND SPAIN

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the year ending 31 December 2015 prior to entering its close period.

 

Overall trading is consistent with expectations at the time of the third quarter trading statement in October. At constant exchange rates, Group revenue growth for the year is expected to be approximately 5%, principally due to the positive impact of acquisitions together with some organic growth which continues to be affected by price declines on plastic resin based products, particularly in North America. The Group operating margin should be at the same level as the prior year.

 

Acquisitions continue to be a key part of the Company's strategy for growth and Bunzl also today announces that it has purchased three further businesses in France, Chile and Spain.

 

Comatec SAS, which is based in Carcassonne, France, is engaged in the distribution of high-end, innovative single use tableware to restaurants and hotels throughout France but also exports products to a large number of distributors in a number of countries worldwide. Revenue in the year ended 31 December 2015 is expected to be €19 million.

 

Bunzl has also acquired Emilio Saray Y Compania Limitada, trading as DPS, a distributor of catering disposables and a variety of cleaning, safety and packaging products based in Santiago with a number of other locations throughout Chile. Customers include wholesalers and distributors as well as restaurants, supermarkets and other end users. Revenue in 2015 is expected to be CLP25.4bn (c.£24 million).

 

Finally in Spain the Company has purchased Faru S.L. Based in Zaragoza, the business is engaged in the sale of personal protection equipment, including fall arrest and head protection products and safety shoes, to distributors throughout Spain. Revenue in 2015 is expected to be €5 million.

 

The Company has now acquired 21 businesses so far this year with a total committed acquisition spend of £320 million which is a record level of spend for Bunzl in any one year. Bunzl's strong cash flow and balance sheet and the continuing promising pipeline of further acquisition opportunities should enable the Group to consolidate further the markets in which it competes and continue to increase shareholder value.

 

Commenting on the acquisitions, Michael Roney, Chief Executive of Bunzl, said:

 

"The acquisition of Comatec is a significant addition to our strong business in France and expands our operations into the foodservice sector where we are already a leader in many countries. The purchase of DPS in Chile extends our business there into the foodservice and cleaning and hygiene sectors in a country where we have previously built a strong anchor position in the safety sector. Faru will complement our existing safety business in Spain by further enhancing our product offering. We are pleased to welcome the employees of all three businesses to the Group."

 

Enquiries:

Bunzl plc

Michael Roney, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Stephen Malthouse

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSBDDGBBBGUU
Date   Source Headline
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding
18th Apr 20248:00 amRNSAdditional Listing
11th Apr 20248:00 amRNSAdditional Listing
3rd Apr 20245:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:09 amRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
21st Mar 20248:00 amRNSAdditional Listing
15th Mar 20243:28 pmRNSAnnual Financial Report
7th Mar 20248:00 amRNSAdditional Listing
5th Mar 20245:05 pmRNSDirector/PDMR Shareholding
4th Mar 20243:03 pmRNSDirector/PDMR Shareholding
1st Mar 202411:35 amRNSTotal Voting Rights
28th Feb 20243:17 pmRNSDirector/PDMR Shareholding
27th Feb 20245:26 pmRNSDirector/PDMR Shareholding
26th Feb 202410:30 amRNSDividend Declaration
26th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSAcquisition
5th Feb 20242:20 pmRNSDirector/PDMR Shareholding
1st Feb 20245:08 pmRNSTotal Voting Rights
12th Jan 20244:54 pmRNSDirector/PDMR Shareholding
11th Jan 20243:50 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:57 amRNSTotal Voting Rights
15th Dec 20235:10 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTrading Statement
8th Dec 20235:32 pmRNSDirector/PDMR Shareholding
1st Dec 202311:32 amRNSTotal Voting Rights
20th Nov 20236:30 pmRNSPublication of Admission Particulars
3rd Nov 20239:30 amRNSDirector Declaration
2nd Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 202311:24 amRNSTotal Voting Rights
1st Nov 20239:00 amRNSBlock listing Interim Review
24th Oct 20237:00 amRNSTrading Statement
6th Oct 20235:08 pmRNSDirector/PDMR Shareholding
4th Oct 20231:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:34 pmRNSTotal Voting Rights
2nd Oct 20231:33 pmRNSDirector/PDMR Shareholding
26th Sep 20232:10 pmRNSDirector/PDMR Shareholding
1st Sep 20232:30 pmRNSTotal Voting Rights
31st Aug 202310:30 amRNSDirector/PDMR Shareholding
29th Aug 202310:00 amRNSDividend Declaration
29th Aug 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSAcquisition
15th Aug 20237:00 amRNSAcquisition
2nd Aug 20233:45 pmRNSDirector/PDMR Shareholding
1st Aug 202311:17 amRNSTotal Voting Rights
13th Jul 20234:20 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSOutcome of audit tender process
11th Jul 20234:50 pmRNSDirector/PDMR Shareholding
6th Jul 202310:44 amRNSDirector/PDMR Shareholding
3rd Jul 20234:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.